DEVELOPHARMA Trademark

Trademark Overview


On Friday, July 7, 2006, a trademark application was filed for DEVELOPHARMA with the United States Patent and Trademark Office. The USPTO has given the DEVELOPHARMA trademark a serial number of 79026815. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, June 27, 2014. This trademark is owned by RIVOPHARM S.A.. The DEVELOPHARMA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, both prescription and over-the-counter, namely pharmaceutical preparations for peptic ulcer and gastroesophageal reflux disease (GORD), propulsives, intestinal anti-infectives, intestinal anti-inflammatory agents, oral pharmaceutical preparations for lowering blood glucose, Vitamin A and D, mixed vitamin preparations consisting of vitamins A and D, vitamin and mineral preparations for medical use, vitamin C in the nature of ascorbic acid, mixed vitamin preparations consisting partially of Vitamin C, calcium supplements, mineral supplements, anti-thrombotic agents, intravenous solutions, cardiac glycosides, class I and class III anti-arrhythmics, pharmaceutical preparations for cardiac stimulation excluding cardiac glycosides, Vasodilators used in the treatment of cardiac diseases, anti-adrenergic agents, pharmaceutical preparations for acting on arteriolar smooth muscle, Beta blocking agents, Selective calcium channel blockers, pharmaceutical preparations i...
developharma

General Information


Serial Number79026815
Word MarkDEVELOPHARMA
Filing DateFriday, July 7, 2006
Status709 - CANCELLED - SECTION 71
Status DateFriday, June 27, 2014
Registration Number3340194
Registration DateTuesday, November 20, 2007
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 4, 2007

Trademark Statements


Goods and ServicesPharmaceutical preparations, both prescription and over-the-counter, namely pharmaceutical preparations for peptic ulcer and gastroesophageal reflux disease (GORD), propulsives, intestinal anti-infectives, intestinal anti-inflammatory agents, oral pharmaceutical preparations for lowering blood glucose, Vitamin A and D, mixed vitamin preparations consisting of vitamins A and D, vitamin and mineral preparations for medical use, vitamin C in the nature of ascorbic acid, mixed vitamin preparations consisting partially of Vitamin C, calcium supplements, mineral supplements, anti-thrombotic agents, intravenous solutions, cardiac glycosides, class I and class III anti-arrhythmics, pharmaceutical preparations for cardiac stimulation excluding cardiac glycosides, Vasodilators used in the treatment of cardiac diseases, anti-adrenergic agents, pharmaceutical preparations for acting on arteriolar smooth muscle, Beta blocking agents, Selective calcium channel blockers, pharmaceutical preparations in the nature of Angiotensin Converting Enzyme inhibitors, pharmaceutical preparations in the nature of Angiotensin Converting Enzyme inhibitors combined with other pharmaceutical preparations, anti-fungals for systemic use, anti-infectives and antiseptics, excluding those combined with corticosteroids, oxytocics, plain corticosteroids for systemic use, thyroid preparations, anti-thyroid preparations, tetracyclines preparations, macrolides, lincosamides and streptogramins, aminoglycoside antibacterials, quinolone antibacterials, antimycotics for systemic use, direct acting antivirals, immune sera, bacterial vaccines, alkylating agents, anti-metabolites, plant alkaloids, cytotoxic antibiotics, hormone antagonists and related agents, namely anti-estrogens, anti-androgens and enzyme inhibitors, immunosuppressive agents, anti-inflammatory and anti-rheumatic preparations, non-steroids in the nature of butylpyrazolidines, acetic acid derivatives, oxicams, propionic acid derivatives, fenamates, Coxibs, muscle relaxants, peripherally acting agents in the nature of curare alkaloids and choline derivatives, antigout preparations, analgesics and antipyretics preparations, anti-migraine preparations, anti-epileptic preparations, anti-cholinergic agents, dopaminergic agents, anti-psychotics, anxiolytics, hypnotics and sedatives, antidepressants, parasympathomimetics, agents for use against amoebiasis and other protozoal diseases, anti-malarial preparation, adrenergics, inhalant anesthetics, adrenergics for systemic use, antihistamines for systemic use, diuretic agents

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, June 27, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameRIVOPHARM S.A.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH-6928 Manno
CH

Party NameRIVOPHARM S.A.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH-6928 Manno
CH

Party NameRIVOPHARM S.A.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH-6928 Manno
CH

Trademark Events


Event DateEvent Description
Friday, July 24, 2015TOTAL INVALIDATION PROCESSED BY THE IB
Monday, July 6, 2015TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Monday, July 6, 2015INVALIDATION PROCESSED
Friday, February 27, 2015TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, June 27, 2014CANCELLED SECTION 71
Friday, June 5, 2009FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, February 27, 2008FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, February 27, 2008FINAL DISPOSITION PROCESSED
Wednesday, February 20, 2008FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, November 20, 2007REGISTERED-PRINCIPAL REGISTER
Tuesday, September 4, 2007PUBLISHED FOR OPPOSITION
Wednesday, August 15, 2007NOTICE OF PUBLICATION
Tuesday, May 29, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, May 29, 2007ASSIGNED TO LIE
Thursday, May 10, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 18, 2007TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 18, 2007CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 18, 2007TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, February 6, 2007NON-FINAL ACTION MAILED
Monday, February 5, 2007NON-FINAL ACTION WRITTEN
Monday, January 15, 2007TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 15, 2007CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, January 15, 2007TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, January 5, 2007REFUSAL PROCESSED BY IB
Monday, December 18, 2006NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, December 18, 2006REFUSAL PROCESSED BY MPU
Thursday, December 14, 2006NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, December 13, 2006NON-FINAL ACTION WRITTEN
Wednesday, December 6, 2006ASSIGNED TO EXAMINER
Friday, September 8, 2006NEW APPLICATION ENTERED IN TRAM
Thursday, September 7, 2006SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB